| 1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|
| 2 |
Boutet M, Gauthier L, Leclerc M, et al. TGFbeta signaling intersects with CD103 integrin signaling to promote T-Lymphocyte accumulation and antitumor activity in the lung tumor microenvironment[J]. Cancer Res, 2016, 76(7): 1757-1769.
|
| 3 |
Ko JC, Chen JC, Wang TJ, et al. Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells[J]. Biochem Pharmacol, 2016, 105: 91-100.
|
| 4 |
Schweers RL, Zhang J, Randall MS, et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation[J]. Proc Natl Acad Sci USA, 2007, 104(49): 19500-19505.
|
| 5 |
Schwarten M, Mohrluder J, Ma P, et al. Nix directly binds to GABARAP: a possible crosstalk between apoptosis and autophagy[J]. Autophagy, 2009, 5(5): 690-698.
|
| 6 |
Panigrahi DP, Praharaj PP, Bhol CS, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics[J]. Semin Cancer Biol, 2020, 66: 45-58.
|
| 7 |
Sowter HM, Ferguson M, Pym C, et al. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade[J]. J Pathol, 2003, 201(4): 573-580.
|
| 8 |
Mellor HR, Harris AL. The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer[J]. Cancer Metastasis Rev, 2007, 26(3-4): 553-566.
|
| 9 |
Xiang Z, Mo Z, Li G, et al. 125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments[J]. Oncotarget, 2016, 7(14): 18384-18393.
|
| 10 |
Feng L, Tong R, Liu X, et al. A network-based method for identifying prognostic gene modules in lung squamous carcinoma[J]. Oncotarget, 2016, 7(14): 18006-18020.
|
| 11 |
Sherwood JL, Corcoran C, Brown H, et al. Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC)[J]. PLoS One, 2016, 11(2): e150197.
|
| 12 |
Jung J, Zhang Y, Celiku O, et al. Mitochondrial NIX promotes tumor survival in the hypoxic niche of glioblastoma[J]. Cancer Res, 2019, 79(20): 5218-5232.
|
| 13 |
Humpton TJ, Alagesan B, Denicola GM, et al. Oncogenic KRAS Induces NIX-mediated mitophagy to promote pancreatic cancer[J]. Cancer Discov, 2019, 9(9): 1268-1287.
|
| 14 |
Hrustanovic G, Bivona TG. RAS signaling in ALK fusion lung cancer[J]. Small GTPases, 2016, 7(1): 32-33.
|
| 15 |
付 洁，吴 斌. 阿法替尼在EGFR突变的晚期非小细胞肺癌患者治疗中的预算影响分析[J]. 中国现代应用药学，2019, 36(6): 723-725.
|
| 16 |
Palikaras K, Lionaki E, Tavernarakis N. Mitophagy: In sickness and in health[J]. Mol Cell Oncol, 2016, 3(1): e1056332.
|
| 17 |
Liu X, Lu X, Zhen F, et al. LINC00665 induces acquired resistance to gefitinib through recruiting EZH2 and activating PI3K/AKT pathway in NSCLC[J]. Mol Ther Nucleic Acids, 2019, 16: 155-161.
|
| 18 |
Dong Q, Yu P, Ye L, et al. PCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrations[J]. Sci Rep, 2019, 9(1): 5692.
|
| 19 |
Wang J, Zhou P, Wang X, et al. Rab25 promotes erlotinib resistance by activating the beta1 integrin/AKT/beta-catenin pathway in NSCLC[J]. Cell Prolif, 2019: e12592.
|
| 20 |
Zhang Z, Zhang M, Liu H, et al. AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells[J]. J Cell Biochem, 2019, 120(1): 756-767.
|
| 21 |
Li W, Chen H, Li S, et al. Exploring microRNAs on NIX-dependent mitophagy[J]. Methods Mol Biol, 2018, 1759: 111-121.
|
| 22 |
Rogov VV, Suzuki H, Marinkovic M, et al. Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins[J]. Sci Rep, 2017, 7(1): 1131.
|
| 23 |
Yamano S, Gi M, Tago Y, et al. Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas[J]. Cancer Sci, 2016, 107(2): 123-132.
|
| 24 |
Taverna S, Giallombardo M, Gil-Bazo I, et al. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice[J]. Oncotarget, 2016, 7(19): 28748-28760.
|
| 25 |
Chen CY, Jan CI, Pi WC, et al. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer[J]. Oncotarget, 2016, 7(13): 16760-16772.
|
| 26 |
Sano H, Futamura M, Gaowa S, et al. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers[J]. Biochem Biophys Res Commun, 2020, 529(3): 582-589.
|
| 27 |
Claude-Taupin A, Fonderflick L, Gauthier T, et al. ATG9A is overexpressed in triple negative breast cancer and its in vitro extinction leads to the inhibition of pro-cancer phenotypes[J]. Cells, 2018, 7(12): 248.
|
| 28 |
Madhu V, Boneski PK, Silagi E, et al. Hypoxic regulation of mitochondrial metabolism and mitophagy in nucleus pulposus cells is dependent on HIF-1alpha-BNIP3 axis[J]. J Bone Miner Res, 2020, 35(8): 1504-1524.
|
| 29 |
Aerbajinai W, Giattina M, Lee YT, et al. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation[J]. Blood, 2003, 102(2): 712-717.
|
| 30 |
Lu Y, Wang L, He M, et al. Nix protein positively regulates NF-kappa B activation in gliomas[J]. PLoS One, 2012, 7(9): e44559.
|
| 31 |
Sowter HM, Ferguson M, Pym C, et al. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade[J]. J Pathol, 2003, 201(4): 573-580.
|
| 32 |
Brennan LA, Mcgreal-Estrada R, Logan CM, et al. BNIP3L/NIX is required for elimination of mitochondria, endoplasmic reticulum and Golgi apparatus during eye lens organelle-free zone formation[J]. Exp Eye Res, 2018, 174: 173-184.
|